Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL).

CONCLUSION: The PCa detection rate in the low-PSA group was not lower than that of previous studies of patients with PSA from 4.0 to 10.0 ng/mL. Further, it may be helpful to define a strategy for PCa detection using PSAD in the low-PSA group. PMID: 33107227 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33107227?dopt=Abstract

Source: J Korean Med Sci - October 26, 2020 Category: General Medicine Authors: Chung JH, Yu J, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Jeon SS Tags: J Korean Med Sci Source Type: research